{"url_path":"/sec/asmb/8-k/2026-06-05/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1426800/0001193125-26-259481-index.html","accession_number":"0001193125-26-259481","cik":"0001426800","ticker":"ASMB","issuer_name":"ASSEMBLY BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1426800/0001193125-26-259481-index.html","primary_entity_key":"0001426800","primary_entity_name":"ASSEMBLY BIOSCIENCES, INC."},"word_count":109,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\n\nNumber\n\nDescription\n\n10.1\n\n[Amendment No. 3 to Assembly Biosciences, Inc. Amended and Restated 2018 Stock Incentive Plan.](asmb-ex10_1.htm)\n\n10.2\n\n[Amendment No. 2 to Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan.](asmb-ex10_2.htm)\n\n104\n\n Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n2\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nAssembly Biosciences, Inc.\n\nDate: June 5, 2026\n\nBy:\n\n/s/ John O. Gunderson\n\nJohn O. Gunderson\n\nVP, General Counsel and Corporate Secretary\n\n \n\n3"}